Related references
Note: Only part of the references are listed.
Article
Cardiac & Cardiovascular Systems
Dose-finding, safety, and tolerability study of an oral platelet glycoprotein IIb/IIIa inhibitor, lotrafiban, in patients with coronary or cerebral atherosclerotic disease
RA Harrington et al.
CIRCULATION (2000)
Share Paper
